跳至主要内容
临床试验/NCT06279065
NCT06279065招募中不适用

Investigation of the Influence of the Human Microbiome on the Pathogenesis and Recurrence Probability in Giant Cell Arteritis

University of Bonn2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2024年2月29日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
50
试验地点
2
主要终点
Significant differences in the composition of the microbiome

研究概览

简要总结

The longitudinal observational study aims to assess the impact of the microbiome especially the gut-microbiome in the emergence and course of giant cell arteritis (abbr. GCA) patients. At diagnosis and 6 month follow up we will analyze the oral, blood and gut microbiome from GCA patients and healthy controls. Thereby identified potential candidate biota will be further analyzed for possible interactions and influence on the immune system.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Giant cell arteritis (only in one arm)

排除标准

  • chronic infection (viral, fungi, bacteria) including human immunodeficiency viruses, Hepatitis B/C
  • acute infection with usage of antibiotics less then 90 days before screening
  • major gastro-intestinal surgery <5 years from screening
  • gastro-intestinal bleeding <90 days before screening
  • inflammatory bowel disease (confirmed bioptically)
  • bulimia or anorexia nervosa
  • adipositas (body mass index ≥ 40)
  • intake of high dosage of probiotics (>10^9 colony forming units per day) <90 days before screening
  • not controlled Diabetes mellitus
  • Malignancy within one year (except for squamous skin - and basal skin carcinoma without metastasis, cervix carcinoma with curative surgery, Cutaneous T-cell lymphoma)
  • known abuse of alcohol oder drugs.

结局指标

主要结局

Significant differences in the composition of the microbiome

时间窗: At Baseline and 6 month follow up

次要结局

  • Influence of the microbiome on therapy response e.g. increased probability of recurrence with accumulation of specific microbiome species(At Baseline and 2 year follow up)
  • potential association of microbiome composition with application of immune modulating drugs(At Baseline and 6 month follow up)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Valentin Schäfer

Head of the rheumatology department, University Hospital Bonn

University of Bonn

研究点 (2)

Loading locations...

相似试验